Biocartis NV
Latest round
- Series F
Last raised
- Jul 2014
Total raised
- $377M
Investors
- 17
About Biocartis NV
Founded in 2007 and headquartered in Mechelen, Belgium, Biocartis NV focuses on molecular testing solutions in the healthcare sector.Biocartis develops advanced biotechnology solutions, primarily through its Idylla™ platform, a fully automated, real-time PCR-based system delivering molecular biomarker results within three hours. The platform includes various assays, including the POLE-POLD1 Mutation Assay and the MSI Test, catering to oncologists, pathologists, and laboratories globally. The company also plans to penetrate new markets in Asia and North America by 2025, focusing on increasing access to its molecular diagnostic solutions.
Who invested in Biocartis NV
17 investors across 7 rounds
See all investors in Biocartis NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Jul 29, 2014
Amount
$146M
Investors
Series E
Dec 19, 2013
Amount
$28M
Investors
Series D
Dec 12, 2012
Amount
$45M
Investors
Series C
Nov 17, 2011
Amount
$98M
Investors
Series B
Sep 1, 2010
Amount
$6.4M
Investors
Series B
Apr 8, 2010
Amount
$40M
Investors
Series A
Oct 15, 2009
Amount
$15M
Investors
Questions about Biocartis NV
Who invested in Biocartis NV?
Biocartis NV has 17 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biocartis NV raised?
Biocartis NV has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Biocartis NV last raise money?
Biocartis NV's most recent round on record is a Series F, in Jul 2014.
What does Biocartis NV do?
Founded in 2007 and headquartered in Mechelen, Belgium, Biocartis NV focuses on molecular testing solutions in the healthcare sector.
Where is Biocartis NV headquartered?
Biocartis NV is headquartered in Mechelen, Belgium.
Which VCs invest in companies like Biocartis NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Biocartis NV's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Biocartis NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.